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Background: Coronary chronic total occlusions (CTO) are a common ﬁnding among
patients with known coronary disease. There are few data about elderly with
CTO(>75 year old). The aim our study was analyze what factors can determine the
decision making treatment and prognosis on this population.
Methods: Monocentre registry of consecutive CTO patients >75 years. We analyzed
clinical and angiographic characteristics and several risk scores. We compare this
population with the global population of CTO
Results: Between June 2010-December 2012, 711 consecutive patients were
included in our registry. 174 >75 years (medium age 80.3 3.2 y) In the elderly
group we found a higher rate of women (24.7 vs 10.7% p< 0.001) hypertension
(77.6 vs 68.3%, p¼ 0.019), higher ACEF score (2.07 vs 1.62, p< 0.001), Syntax
creatinine score (58.6 vs.39.9, p< 0.001) Syntax logistic score (17.8 vs 12.4, p<
0.001) and Global Syntax score (77.5 % vs 42.5%, p¼0.001). The treatment
choice was left to the cardiologist’s criterion. 29 patients were referred to
percutaneous revascularization (PCI), 21 to surgery (CABG) and 124 to medical
therapy. The tree groups were similar in all factors analyzed but patients managed
by medical therapy were older (80.93.2 vs 78.42.2 PCI vs 79.22.4 CABG;
p< 0.001). Revascularization was less frequent in elderly (CABG (12.1% vs
26.6% p< 0.001) and PCI (16.7 % vs 32.2% p< 0.001)). We made a clinical or
telephone follow-up (1.9  0.9 years). Elderly have a worse prognosis: higher
incidence of acute myocardial infarction (AMI) (12.6 vs 4.5%, p< 0.001), car-
diovascular death (CVD)(20.7 vs 4.5%, p< 0.001) and all causes of death
(ACD)(21.8 vs 8.4% p< 0.001). Patients sent to CABG had the best prognosis
independently of their age. Prognosis in patients sent to PCI was intermediate
between CABG and medical therapy no mater their age. Elderly referred to
medical therapy had the worst prognosis: highest rates of AMI (P< 0.001), ACD
and CVD (P< 0.001)
Conclusions:Most of elderly CTO patients were managed by medical treatment. This
decision had serious prognostic implications, higher rate of AMI and cardiovascular
death. The prognosis of patients sent to revascularization (CABG or PCI) was inde-
pendent on their ageCoronary Lesions - Left Main
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Background: There is a lack of data regarding the outcomes of medical treatment for
stable coronary artery disease (SCAD) involving unprotected left main coronary artery
(ULMCA) stenosis.
Methods: From March 1992 to February 2011, among 3,041 patients enrolled
in ASAN MAIN registry, 411 patients did not receive the revascularization
for ULMCA stenosis. Among those, 122 patients had severe co-morbidities
and 134 patients had intermediate stenosis. Remaining 153 patients were
identiﬁed as “amenable but declined” for the revascularization (medical
treatment group) and compared with those receiving percutaneous coronary
intervention or coronary artery bypass grafting. Primary endpoint was death
from any causes.
Results: The crude 2-year rates of death from any cause (PCI, 3.2%; CABG, 6.8%;
medical treatment, 26.1%; p< 0.001) and the composite of death, myocardial
infarction, or stroke (PCI, 5.0%; CABG, 8.3%; medical treatment, 27.0%; P < 0.001)
were signiﬁcantly higher in medical treatment group. Multivariate Cox’s proportional
hazards model revealed that medical treatment was an independent predictor of death
(HR, 0.164; 95% CI, 0.087 – 0.310; p value < 0.001, compared with PCI; HR, 0.285;JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Co95% CI, 0.169 – 0.481; p value < 0.001, compared with CABG) and the composite of
death, MI, or stroke (HR, 0.271; 95% CI, 0.134 – 0.550; p value < 0.001, compared
with PCI; HR, 0.448; 95% CI, 0.246 – 0.817; p value ¼ 0.009, compared with
CABG).
Conclusions: Although clinical presentation was stable, non revascularized ULMCA
stenosis was associated with the higher mortality.TCT-223
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Background: The aim of this study was to compare the clinical outcomes of un-
protected left main coronary artery (ULMCA) stenting with or without aorto-ostial
coverage.
Methods: From ASAN-MAIN registry, a total of 550 with ULMCA stenosis without
signiﬁcant aorto-ostial stenosis (angiographic diameter stenosis>50%) who were
treated by drug-eluting stent between March 2003 and June 2010 and were catego-
rized into stenting with aortic-ostial coverage (AOC, N¼316) versus stenting without
aorto-ostial coverage (No-AOC, N¼234).
Results: During 2-year follow-up, all-cause mortality (4.7% in No AOC group
vs. 2.8% in AOC group, P¼0.24), myocardial infarction (1.7% in No AOC
group vs. 0.95% in AOC group, P¼0.42), target lesion revascularization (3.0%
in No AOC group vs. 0.63% in AOC group, P¼0.81) were not signiﬁcantly
different. Among 407 patients with angiographic follow-up, LM in-stent
restenosis did not differ between groups (4.3 % in No AOC group vs. 5.1 % in
AOC group; p¼0.66). For aorto-ostial lesion, in-stent restenosis occurred 1
patients (0.32 %) in AOC group and de novo ostial stenosis occurred 4 pa-
tients (1.71 %) in No AOC group (P¼0.316). After Cox regression multivar-
iable analysis, AOC did not affect the death (HR 0.59, 95% CI 0.24-1.43; p¼
0.25), the composite of death, MI, target lesion revascularization (HR 1.02,
95% CI 0.59-1.77; p¼ 0.94).ronary Lesions - Left Main B65
